Altimmune, Inc. (ALT) Tops Q2 EPS by 15c

Altimmune, Inc. (NASDAQ: ALT) reported Q2 EPS of ($0.32), $0.15 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Roblox announces standalone apps, browser play, and creator wallet
• Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day